Thomas Holst Laursen
With more than 25 years of experience, Thomas is one of the most experienced transaction lawyers in the market, having handled several of the largest and most complex transactions in the Danish market (including the Novonesis merger, SAS restructuring and acquisition, and Simcorp) and the market's recent IPOs (Netcompany and Gubra).
With transactions worth more than EUR 61 billion and 144 transactions (source: MergerMarket), Thomas is one of the highest ranked and recognised transaction lawyers in the market in both numbers and value. Thomas concentrates on M&A and capital markets transactions.
According to Mergerlinks, Thomas ranks as "the No. 1 Top M&A Lawyer in Denmark" in 2023 and leads the market in all recognised rankings of Danish transactional lawyers (Chambers, Legal500, etc.).
Thomas mainly focuses on assisting corporate clients and foundations. Thomas' experience includes M&A mandates, cross-border M&A, take-private transactions, IPOs, ABBs, rights issues, and JV/merger transactions.
Thomas has a Master’s degree in Law from the University of Copenhagen and Cambridge University.
Almost all the matters that Thomas is involved in require a multi-disciplinary team approach and project leadership. Clients continuously seek him and the team for their ability to provide a clear set of priorities, clear communication, and a deep commercial understanding of the client's needs.
Selected cases
IPOs of Netcompany, Gubra, ISS, Ørsted, Orphazyme, Scandinavian Tobacco Group, Maersk Drilling, Zealand Pharma, NTG, etc.
M&A transactions e.g. Santaris Pharma, Symphogen, EET, Flying Tiger, acquisition of Circle K, Norlys (infrastructure), Creativ Company, Union, KK Engineering, CEGO, Durascan, PrecisionBiotics Group, etc.
Sale of Santaris Pharma, Symphogen, EET, Flying Tiger, etc.
Sivantos and Widex - merger between Sivantos and Widex
Nordjyske Bank A/S - adviser to the company in connection with a public take-over offer
Veloxis Pharmaceuticals A/S - adviser to the company in connection Asahi Kasei's public take-over offer
LEO Foundation and LEO Pharma - adviser to LEO Foundation and LEO Pharma in connection with Nordic Capital's EUR 450 million investment in LEO Pharma
Noble Corporation - adviser to Noble in connection with the take-over of Maersk Drilling
TDC A/S - adviser to consortium in connection with the consortium's voluntary take-over bid for TDC
The Danish Ministry of Finance and Ørsted – Ørsted (DONG Energy) transaction with Goldman Sachs, ATP and PFA, and the subsequent IPO of Ørsted
The Danish Ministry of Finance – advice in connection with the entering into of an investment agreement between SAS AB and a consortium
Novozymes (now Novonesis) – the merger between Novozymes and Chr. Hansen (the largest merger in Danish history)
Deutsche Börse AG and SimCorp A/S - advisor to Deutsche Börse in connection with its public takeover offer to the shareholders of SimCorp A/S
Dansk Ejerkapital, three professional investors and management to acquire Creativ Company
emagine acquires Boost IT
Visma announces all-cash voluntary recommended public takeover offer for Penneo
Nobilis Group GmbH set to acquire TMC Nordic A/S
Sønderborg Varme og Broager Fjernvarme sammenlægges
Wellvita Group acquires Natupharma A/S and becomes market leader in the Nordics
Aarstiderne sold to Dagrofa
7N sold to Polaris Private Equity
Puzzel to acquire Capturi
emagine to acquire Allgeier Experts
Digital Group acquires XDC Gruppen
Sampo plc successfully completes its public exchange offer to the shareholders of Topdanmark A/S
Ford to divest Ford Motor Company A/S and its Danish import business to Nic. Christiansen Group
Sampo plc completes dual listing on Nasdaq Copenhagen
Copilot Capital acquires Danish SaaS company PriceShape
Jyske Finans acquires Opendo's private leasing and fleet management portfolio
Axcel-backed Tic elkas/Eegholm/Elcor group acquires Elektro Aros Elautomation
Ramboll to acquire K2 Management to strengthen global wind division
Standard Motor Products to acquire Nissens Automotive
Plesner has assisted our long-time client Zealand Pharma with a record equity raise through an accelerated bookbuilding offering in a private placement raising proceeds of USD 1 billion / DKK 7 billion
Sampo plc announces a public exchange offer to the shareholders of Topdanmark A/S
Magellan Capital Holdings acquires majority stake in Danmarks Skibskredit A/S
Bridgepoint acquires MyDefence
Wegener to acquire the Danish steel business Ib Andresen Industri
Svitzer Group A/S is listed on Nasdaq Copenhagen
Dürr Group sells Agramkow Fluid Systems A/S to Solix Group AB
Edenred to acquire Spirii
Solina group to acquire the premium culinary brands, OSCAR and Puljonki
Plesner advises on the successful sale of Parcel4You to Link Logistics
The largest merger in Danish history completed today
Capidea invests in Digital Group
Novozymes and Chr. Hansen obtains competition clearance in Phase I
SKAKO Concrete divests its Concrete division to Zefyr Invest IV
Ahlsell has entered into an agreement to acquire Bacher Work Wear
Emerson invests in Frugal Technologies
SAS enters into investment agreement as part of its reorganization process
General Atlantic acquires majority stake in Joe & the Juice
Deutsche Börse AG successfully completes takeover of SimCorp A/S
Nets enters into an agreement to divest its eID business to IN Groupe
Agilitas completes sale of the Reconor Group
Teledyne Technologies acquires Xena Networks
Plesner advised Nordic Solar with EUR 300m flexible credit facility
IK Partners to sell Løgismose
PenSam Pension divests subsidiary PenSam Forsikring
Funds advised by Agilitas complete the buy-out of NNIT’s IT infrastructure outsourcing business
Deutsche Börse AG announces public takeover offer for SimCorp A/S
Zealand Pharma completes a successful accelerated bookbuilding offering of DKK 1.5 billion
"He is sharp and analytical – but with a sound pragmatic approach" (2023)
"Very strong overall, very commercial, to the point, tells it like it is and does not hold back in negotiations" (2023)
"Very pleasant and knowledgeable. Probably the best lawyer of his generation" (2023)
"Bright, engaging, commercially aware and always professional and collegiate in manner" (2023)
"He is always very open and transparent. He has a friendly nature and has very broad experience. His communication is most often very clear and his knowledge on specific areas is often very deep. He is especially good at strategic advisory. He always does what he promises and his availability is fantastic" (2022)
"Highly skilled; makes things happen; client-first attitude" (2022)
"Thomas Holst Laursen provides thorough solutions. He has a pragmatic and solutions-oriented approach to the challenges presented. He understands the commercial angle and remembers the personal angle can be important, too" (2021/2022)
"Thomas Holst Laursen is the natural leader of the firm and is truly a pleasure to work with"
"Thomas Holst Laursen has superb knowledge and a practical pragmatic approach"
"Thomas has a great approach and is very commercial and knowledgeable" (2024)
"He has strong negotiation skills and a deep knowledge in the nature of transactions" (2024)
Thomas Holst Laursen is a highly regarded practitioner in the field and is particularly noted for his prowess in equity capital market transactions. His areas of strength also include tender offers, company acquisitions and demergers. Clients enthuse that he is "extremely efficient and very commercial. He understands what is important and what is not, so he goes straight to the point" (2022)
"Thomas Holst Laursen is seasoned and very sharp" (2023)
"Thomas Holst Laursen is taking a very holistic and considered approach to the legal issues related to the company transition we are working on" (2022)